Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maingon

Showing results (311-320 of 340) with videos related to

Pageof 34
Sort By:
JAMA Network Open|February 3, 2026
Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical TrialJulian Biau, Xushan Sun, Xavier Liem, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
The Lancet. Oncology|December 16, 2014
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialHarry Bartelink, Philippe Maingon, Philip Poortmans, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2019
[Chemoradiation for oesophageal cancer: A critical review of the literature]E Blais, V Vendrely, P Sargos, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)]C Marchal, M Lapeyre, V Beckendorf, et al.
Frontiers in Oncology|November 29, 2023
A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imagingJessica Prunaretty, Gorkem Güngör, Thierry Gevaert, et al.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Michel Bolla, Philippe Maingon, Christian Carrie, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
Pageof 34

Showing results (311-320 of 340) with videos related to

Sort By:
Pageof 34
JAMA Network Open|February 3, 2026
Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical TrialJulian Biau, Xushan Sun, Xavier Liem, et al.
JAMA Oncology|October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysisAmar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
The Lancet. Oncology|December 16, 2014
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialHarry Bartelink, Philippe Maingon, Philip Poortmans, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2019
[Chemoradiation for oesophageal cancer: A critical review of the literature]E Blais, V Vendrely, P Sargos, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)]C Marchal, M Lapeyre, V Beckendorf, et al.
Frontiers in Oncology|November 29, 2023
A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imagingJessica Prunaretty, Gorkem Güngör, Thierry Gevaert, et al.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Michel Bolla, Philippe Maingon, Christian Carrie, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
Pageof 34